News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer
Thursday, February 23, 2023Roche announced today the launch of the IDH RH MRQ Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody to identify mutation status in patients diagnosed with brain cancer A brain tumour is formed when there is an abnormal growt...
EureKARE co-founds EonBio to revolutionize drug discovery with pioneering cell-free technology on a chip
Wednesday, February 22, 2023EureKARE an innovative investment company for disruptive synthetic biology applications announces the second company to be supported and housed in its biomedical startup studio in Brussels Belgium EonBio is developing a cuttingedge platform to addres...
FDA Accepts Valneva’s Chikungunya Vaccine License Application for Priority Review
Tuesday, February 21, 2023Valneva SE a specialty vaccine company today announced that the US Food and Drug Administration FDA has completed a filing review of its Biologics License Application for Valnevas singleshot chikungunya vaccine candidate VLA and has determined that t...
Medivir has determined the recommended phase 2 dose for fostrox in combination with Lenvima in HCC
Tuesday, February 21, 2023Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that the initial dose escalation part phase b of the companys ba study with the candidate drug fostroxacita...
Formosa Pharmaceuticals Announces Development Collaboration Agreement with Eyenovia
Thursday, February 16, 2023Taiwanbased Formosa Pharmaceuticals announced today that the company has entered into a collaboration agreement with Eyenovia Inc for the development of novel ophthalmic therapeutics The foundation of the collaboration lies in the combination of Form...
Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration
Thursday, February 16, 2023Charles River Laboratories International Inc and Purespring Therapeutics a pioneering gene therapy company focused on transforming the treatment of kidney diseases today announced a plasmid DNA contract development and manufacturing organization CDMO...
Exelixis and Sairopa Announce US FDA Clears Investigational New Drug Application for ADU-1805 in Patients with Advanced Solid Tumors
Wednesday, February 15, 2023Exelixis Inc and Sairopa BV Sairopa today announced that the US Food and Drug Administration FDA has cleared Sairopas Investigational New Drug IND Application to evaluate the safety and pharmacokinetics of ADU in adults with advanced solid tumors As...
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine
Wednesday, February 15, 2023Telix Pharmaceuticals Limited announces the successful completion of its joint research project conducted with Heidelberg University Hospital UKHD under the Research Cooperation Agreement announced in February The aim of this project was to create a...
Lilly and IABL Collaborate to Ensure Patient Access to High-Quality Affordable Insulin in Bangladesh
Tuesday, February 14, 2023Eli Lilly and Company will supply its active pharmaceutical ingredient API for human insulin at a reduced price to International Agencies Bangladesh Ltd IABL in an effort to increase patient access and improve affordability for highquality insulin fo...
NurExone Biologic Inc. Emerges as a Promising Investment Opportunity in Biotechnology
Tuesday, February 14, 2023NurExone Biologic Inc a Torontolisted biopharmaceutical company is developing ExoPTEN a proprietary platform for producing and loading exosomes with pharmaceutical cargo targeting spinal cord injuries SCI intranasally NurExone has established itself...
